Coordinación
Carrer Baldiri Reixac, 4-8
08028 Barcelona
93 403 11 02 / reem@reem.es
1. Neuroimmunology line
2. Neurodegeneration / Regeneration line
3. Genomics line
4. Virus line
5. Biomarker line
6. Clinical marker for MS treatment line
7. New therapies line
Coordinator: Xavier Montalbán
Groups:
Hospital Ramón y Cajal
Hospital Clínic de Barcelona
Hospital Universitario San Carlos
Hospital Carlos Haya
Objetives: Identify clinical and IRM variables that may predict the clinical course and the response to immunomodulative treatment (interferon beta or Glatiramer acetare) towards improving our ability of predicting the clinical course of MS and deciding the more accurate therapy for each patient. The long term objective would be to develop a more personalized treatment for patients suffering MS.
Macroprojects:
 |
 |
 |
 |
 |
 |